Genetic ablation of PIM kinase (PIM-1/2/3) or PIM inhibitor can induce apoptosis in DLBCL cell lines, providing new therapeutic hope targets for the disease [19]. The gene discussed is PIM1; the disease is diffuse large B-cell lymphoma.